Propensity score analysis of overall survival between first‐ and second‐generation EGFR‐TKIs using real‐world data

We constructed a data set of EGFR‐mutant non–small‐cell lung carcinoma (NSCLC) patients, and compared the overall survival of first‐generation (1G), and second‐generation (2G) EGFR‐tyrosine kinase inhibitors (TKIs) in clinical practice using a propensity score. We reviewed the clinical data of conse...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Kentaro, Murotani, Kenta, Kubo, Akihito, Kunii, Eiji, Taniguchi, Hirokazu, Shindoh, Joe, Asada, Kazuhiro, Imaizumi, Kazuyoshi, Takahashi, Kosuke, Karayama, Masato, Okuno, Motoyasu, Inui, Naoki, Hataji, Osamu, Morikawa, Sayako, Hayai, Shunsaku, Suda, Takafumi, Abe, Takashi, Tsuda, Takeshi, Yamagichi, Teppei, Kimura, Tomoki, Oya, Yuko, Yoshida, Tatsuya, Hida, Toyoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541013/
https://www.ncbi.nlm.nih.gov/pubmed/32639668
http://dx.doi.org/10.1111/cas.14560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541013/
https://www.ncbi.nlm.nih.gov/pubmed/32639668
http://dx.doi.org/10.1111/cas.14560

Ejemplares similares